TR200000134T2 - Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi. - Google Patents
Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi.Info
- Publication number
- TR200000134T2 TR200000134T2 TR2000/00134T TR200000134T TR200000134T2 TR 200000134 T2 TR200000134 T2 TR 200000134T2 TR 2000/00134 T TR2000/00134 T TR 2000/00134T TR 200000134 T TR200000134 T TR 200000134T TR 200000134 T2 TR200000134 T2 TR 200000134T2
- Authority
- TR
- Turkey
- Prior art keywords
- diabetes
- thiazolidinedione
- biguanide
- treatment
- insulin secretagogue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Etkili, toksin olmayan ve eczacilik teknolojisi bakimindan kabul edilebilir tutarda bir ensülin yönünden duyarli duruma getiricinin, bir insülin salgilattiricisinin bir biguanid, bunlara gereksinmesi bulunan bir memeliye verilmesini içeren diabetes mellitus'un ve memelide diabetes mellitus ile iliskili durumlarin tedavi edilmeleri için yöntem ile bu gibi yöntemin kullanilmasina yarar bilesim.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9715295A GB9715295D0 (en) | 1997-07-18 | 1997-07-18 | Novel method of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200000134T2 true TR200000134T2 (tr) | 2000-09-21 |
Family
ID=10816167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/00134T TR200000134T2 (tr) | 1997-07-18 | 1998-07-16 | Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi. |
Country Status (40)
Country | Link |
---|---|
EP (1) | EP1001783B1 (tr) |
JP (2) | JP2001510159A (tr) |
KR (1) | KR100671918B1 (tr) |
CN (1) | CN1264303A (tr) |
AP (1) | AP1352A (tr) |
AR (1) | AR016349A1 (tr) |
AT (1) | ATE305790T1 (tr) |
AU (1) | AU8448898A (tr) |
BG (1) | BG64785B1 (tr) |
BR (1) | BR9810445A (tr) |
CA (1) | CA2296653C (tr) |
CO (1) | CO4940420A1 (tr) |
CY (1) | CY1105254T1 (tr) |
DE (1) | DE69831808T2 (tr) |
DK (1) | DK1001783T3 (tr) |
DZ (1) | DZ2562A1 (tr) |
EA (1) | EA003021B1 (tr) |
ES (1) | ES2251093T3 (tr) |
GB (1) | GB9715295D0 (tr) |
HK (1) | HK1028550A1 (tr) |
HU (1) | HUP0003629A3 (tr) |
ID (1) | ID24211A (tr) |
IL (1) | IL134046A0 (tr) |
IN (1) | IN189275B (tr) |
MA (1) | MA24607A1 (tr) |
MY (1) | MY155219A (tr) |
NO (1) | NO325727B1 (tr) |
NZ (2) | NZ501164A (tr) |
OA (1) | OA11279A (tr) |
PE (1) | PE99599A1 (tr) |
PL (2) | PL198017B1 (tr) |
SA (1) | SA98190468B1 (tr) |
SI (1) | SI1001783T1 (tr) |
SK (1) | SK285484B6 (tr) |
TR (1) | TR200000134T2 (tr) |
TW (1) | TW505516B (tr) |
UA (1) | UA70303C2 (tr) |
UY (1) | UY25102A1 (tr) |
WO (1) | WO1999003477A1 (tr) |
ZA (1) | ZA986363B (tr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6011049A (en) * | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
US6099862A (en) * | 1998-08-31 | 2000-08-08 | Andrx Corporation | Oral dosage form for the controlled release of a biguanide and sulfonylurea |
BR9915285A (pt) * | 1998-11-12 | 2001-08-07 | Smithkline Beecham Plc | Composição farmacêutica para liberação modificada de um sensitivador de insulina e um outro agente antidiabético |
SE9902918D0 (sv) * | 1999-08-13 | 1999-08-13 | Pharmacia & Upjohn Ab | Methods for identification of compounds stimulating insulin secretion |
WO2001035940A2 (en) * | 1999-11-16 | 2001-05-25 | Smithkline Beecham P.L.C. | Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride |
MY125516A (en) * | 1999-11-16 | 2006-08-30 | Smithkline Beecham Plc | Novel composition based on thiazolidinedione and metformin and use |
FR2812547B1 (fr) * | 2000-08-04 | 2002-10-31 | Lipha | Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete |
EP1349531A1 (en) | 2001-01-12 | 2003-10-08 | Sun Pharmaceuticals Industries Ltd. | Spaced drug delivery system |
ITFI20010126A1 (it) * | 2001-07-09 | 2003-01-09 | Molteni & C | Composizioni farmaceutiche per uso orale,contenenti,in combinazione,metformina e gliclazide |
CA2453775A1 (en) * | 2001-07-10 | 2003-01-23 | Kos Life Sciences, Inc. | Core formulation comprising pioglitazone hydrochloride and a biguanide |
EP1515701B1 (en) | 2002-06-17 | 2014-09-17 | Inventia Healthcare Private Limited | Process for the manufacture of multilayer tablet compositions comprising thiazolidinedione and biguanide |
UA80991C2 (en) | 2002-10-07 | 2007-11-26 | Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes | |
HUE028576T2 (en) | 2003-10-31 | 2016-12-28 | Takeda Pharmaceuticals Co | Solid preparation containing pioglitazone, glimepiride and polyoxyethylene sorbitan fatty acid ester |
MXPA05010977A (es) * | 2005-10-12 | 2007-04-11 | Abdala Leopoldo Espinosa | Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus. |
KR100812538B1 (ko) * | 2006-10-23 | 2008-03-11 | 한올제약주식회사 | 약물 제어방출형 메트포르민-글리메피리드 복합제제 |
CN101417130B (zh) * | 2007-10-22 | 2010-10-06 | 鲁南制药集团股份有限公司 | 一种治疗ⅱ型糖尿病及其并发症的药物组合物 |
WO2019078663A2 (ko) * | 2017-10-20 | 2019-04-25 | 주식회사 노브메타파마 | 아연염, 시클로-히스프로 및 항당뇨 약물을 유효성분으로 함유하는 당뇨병 예방 또는 치료용 약학적 조성물 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
JPS5697277A (en) * | 1980-01-07 | 1981-08-05 | Takeda Chem Ind Ltd | Thiazolidine derivative |
JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
US4582839A (en) * | 1984-03-21 | 1986-04-15 | Takeda Chemical Industries, Ltd. | 2,4-thiazolidinediones |
CN1003445B (zh) * | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物,其制备方法和用途 |
JPH06779B2 (ja) * | 1985-06-10 | 1994-01-05 | 武田薬品工業株式会社 | チアゾリジオン誘導体およびそれを含んでなる医薬組成物 |
US4812570A (en) * | 1986-07-24 | 1989-03-14 | Takeda Chemical Industries, Ltd. | Method for producing thiazolidinedione derivatives |
US4791125A (en) * | 1987-12-02 | 1988-12-13 | Pfizer Inc. | Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents |
US5061717A (en) * | 1988-03-08 | 1991-10-29 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
MX15171A (es) * | 1988-03-08 | 1993-05-01 | Pfizer | Derivados de tiazolidinodiona hipoglicemicos |
WO1991007107A1 (en) * | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Oxazolidinedione hypoglycemic agents |
JPH04210683A (ja) * | 1990-12-06 | 1992-07-31 | Terumo Corp | チアゾリジン−2,4−ジオン誘導体およびこれを含有する糖尿病合併症治療薬 |
DK0601001T3 (da) * | 1991-08-26 | 1997-10-20 | Upjohn Co | Flydende næringsmiddelprodukt indeholdende 3-guanidinopropionsyre. |
US5917052A (en) * | 1994-09-28 | 1999-06-29 | Shaman Pharmaceuticals, Inc. | Hypoglycemic agent from cryptolepis |
TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
AP1600A (en) * | 1997-06-18 | 2006-04-28 | Smithkline Beecham Plc | Combination of a thiazolidinedione and a sulphonylurea for treating diabetes |
-
1997
- 1997-07-18 GB GB9715295A patent/GB9715295D0/en active Pending
-
1998
- 1998-07-15 DZ DZ980172A patent/DZ2562A1/xx active
- 1998-07-16 PL PL378474A patent/PL198017B1/pl not_active IP Right Cessation
- 1998-07-16 AU AU84488/98A patent/AU8448898A/en not_active Abandoned
- 1998-07-16 WO PCT/GB1998/002110 patent/WO1999003477A1/en active IP Right Grant
- 1998-07-16 AP APAP/P/2000/001733A patent/AP1352A/en active
- 1998-07-16 NZ NZ501164A patent/NZ501164A/en unknown
- 1998-07-16 NZ NZ511608A patent/NZ511608A/xx unknown
- 1998-07-16 PL PL338126A patent/PL197844B1/pl not_active IP Right Cessation
- 1998-07-16 AT AT98935127T patent/ATE305790T1/de not_active IP Right Cessation
- 1998-07-16 AR ARP980103481A patent/AR016349A1/es unknown
- 1998-07-16 BR BR9810445-4A patent/BR9810445A/pt not_active Application Discontinuation
- 1998-07-16 SI SI9830804T patent/SI1001783T1/sl unknown
- 1998-07-16 TR TR2000/00134T patent/TR200000134T2/tr unknown
- 1998-07-16 IL IL13404698A patent/IL134046A0/xx unknown
- 1998-07-16 EP EP98935127A patent/EP1001783B1/en not_active Expired - Lifetime
- 1998-07-16 PE PE1998000629A patent/PE99599A1/es not_active Application Discontinuation
- 1998-07-16 MA MA25171A patent/MA24607A1/fr unknown
- 1998-07-16 CN CN98807319A patent/CN1264303A/zh active Pending
- 1998-07-16 EA EA200000139A patent/EA003021B1/ru not_active IP Right Cessation
- 1998-07-16 SK SK59-2000A patent/SK285484B6/sk not_active IP Right Cessation
- 1998-07-16 DK DK98935127T patent/DK1001783T3/da active
- 1998-07-16 CA CA002296653A patent/CA2296653C/en not_active Expired - Fee Related
- 1998-07-16 JP JP2000502776A patent/JP2001510159A/ja not_active Withdrawn
- 1998-07-16 ID IDW20000075A patent/ID24211A/id unknown
- 1998-07-16 UA UA2000010261A patent/UA70303C2/uk unknown
- 1998-07-16 DE DE69831808T patent/DE69831808T2/de not_active Expired - Fee Related
- 1998-07-16 HU HU0003629A patent/HUP0003629A3/hu unknown
- 1998-07-16 ES ES98935127T patent/ES2251093T3/es not_active Expired - Lifetime
- 1998-07-16 KR KR1020007000512A patent/KR100671918B1/ko not_active IP Right Cessation
- 1998-07-17 TW TW087111770A patent/TW505516B/zh active
- 1998-07-17 CO CO98040747A patent/CO4940420A1/es unknown
- 1998-07-17 ZA ZA9806363A patent/ZA986363B/xx unknown
- 1998-07-17 MY MYPI98003288A patent/MY155219A/en unknown
- 1998-07-17 UY UY25102A patent/UY25102A1/es not_active IP Right Cessation
- 1998-07-20 IN IN2087DE1998 patent/IN189275B/en unknown
- 1998-08-29 SA SA98190468A patent/SA98190468B1/ar unknown
-
2000
- 2000-01-17 NO NO20000228A patent/NO325727B1/no not_active IP Right Cessation
- 2000-01-18 OA OA1200000012A patent/OA11279A/en unknown
- 2000-02-07 BG BG104135A patent/BG64785B1/bg unknown
- 2000-11-08 HK HK00107103A patent/HK1028550A1/xx not_active IP Right Cessation
-
2005
- 2005-04-21 JP JP2005123562A patent/JP2005213273A/ja active Pending
- 2005-12-07 CY CY20051101486T patent/CY1105254T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200000134T2 (tr) | Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi. | |
TR199903057T2 (tr) | Diabetin tiazolidinedion ve metformin ile tedavisi. | |
TR200100079T2 (tr) | Glikoza karşı ß-hücre tepkisini arttıran glukagon benzeri peptid-1 | |
NO940436L (no) | Forlenget avgivelse av peptider | |
FR2709423B1 (fr) | Réservoir imprégnable d'une solution de principe actif, pour dispositif ionophorétique d'administration transdermique de médicaments, et procédé de fabrication d'un tel réservoir. | |
DE69327309D1 (de) | Verwendung eines peptids | |
YU37301A (sh) | Farmaceutski preparat za modifikovano oslobađanje sensitizera insulina i drugog antidijabetskog agensa | |
TR200100600T2 (tr) | İnsülinotropik peptitlerin kullanımı. | |
DK273090D0 (da) | Laasecylinder og noegle saavel som noegleemne med ens sikkerhedsindretning | |
TR199903095T2 (tr) | Diabetin roziglitazon ve insülin ile tedavisi. | |
TR200503846T2 (tr) | Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı | |
TR200000135T2 (tr) | Tiazolidinedion ve sülfonilüre ile diabet tedavisi. | |
ES2131122T3 (es) | Uso de il-10 para prevenir la diabetes mellitus dependiente de insulina. | |
ATE252913T1 (de) | Vorbeugung einer krankheit mit diabetes charakter | |
TR199801298T2 (tr) | ACE-engelleyicinin dispeptik semptomlarin tedavisinde yeni tibbi kullanimi. | |
TR200000133T2 (tr) | Tiazolidinedion, ensülin salgılattırıcısı ve alfa glükosidaz inhibitörü ile diabetin (şeker hastasının) tedavisi. | |
TR199903072T2 (tr) | Diabetin tiazolidinedion ve alfa-glukosidaz ile tedavisi. | |
AR008025A1 (es) | Combinación farmacéutica de una tiazolidindiona y un secretagogo de insulina | |
TR200101336T2 (tr) | Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar | |
KR890011572A (ko) | 정신 기능을 증진시키는 방법 | |
IL143088A0 (en) | A method for the treatment of type 2 diabetes mellitus and conditions associated therewith, and a pharmaceutical composition comprising an insulin sensitiser for use in such a method | |
HUP0002668A2 (hu) | Diabetes kezelésére dioxo-tiazolidinnel és metforminnal | |
ECSP982534A (es) | Nuevo metodo de tratamiento | |
AP1692A (en) | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent. | |
NO883237L (no) | Tilstrammings- og laasanordning for snorer, remmer el.l. |